We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

40 hedge funds and large institutions have $2.25M invested in Nymox Pharmaceutical Corp in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $2.05M → $2.25M (+$201K)

5% less call options, than puts

Call options by funds: $35K | Put options by funds: $37K

7% less funds holding

Funds holding: 43 → 40 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
7
Closed
11
Calls
$35K
Puts
$37K
Net Calls
-$2K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$168K
2
M
Murchinson
Ontario, Canada
+$118K
3
DDC
DF Dent & Co
Maryland
+$116K
4
CH
CVI Holdings
Delaware
+$71K
5
WP
WMS Partners
Maryland
+$64.8K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$132K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$54K
3
Jane Street
Jane Street
New York
-$33K
4
Millennium Management
Millennium Management
New York
-$28K
5
FTDI
First Trust Direct Indexing
Massachusetts
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAS
26
Kestra Advisory Services
Texas
$15K – – –
Citadel Advisors
27
Citadel Advisors
Florida
$15K +$18.9K +12,240 New
JP Morgan Chase
28
JP Morgan Chase
New York
$14K -$976 -632 -5%
LNC
29
Lincoln National Corp
Pennsylvania
$13K – – –
ODIJL
30
One Day In July LLC
Vermont
$13K – – –
Simplex Trading
31
Simplex Trading
Illinois
$12K -$10.4K -6,760 -41%
Bank of America
32
Bank of America
North Carolina
$12K -$8.83K -5,716 -38%
Osaic Holdings
33
Osaic Holdings
Arizona
$10K – – –
SIAP
34
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$3K – – –
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$2.14K – – –
Rockefeller Capital Management
36
Rockefeller Capital Management
New York
$2K – – –
UBS Group
37
UBS Group
Switzerland
$1K – – –
E
38
Ergoteles
New York
– -$132K -101,332 Closed
Jane Street
39
Jane Street
New York
– -$33K -25,658 Closed
Millennium Management
40
Millennium Management
New York
– -$28K -21,880 Closed
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
– -$15K -11,444 Closed
FTDI
42
First Trust Direct Indexing
Massachusetts
– -$15K -11,315 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$11K -8,417 Closed
PA
44
PSI Advisors
Florida
– -$10K -8,000 Closed
Wells Fargo
45
Wells Fargo
California
– -$10K -7,478 Closed
Optiver Holding
46
Optiver Holding
Netherlands
– -$13K -6,109 Closed
CA
47
Cornerstone Advisory
Maryland
– -$6K -4,536 Closed
1
2

NYMX Hedge Fund Activity: Q1 2022 in Review

40 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2022, worth a combined $2.25M — up 9.8% from $2.05M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NYMX and 8 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was Citigroup, opening a new position worth an estimated $168K. The largest seller was Ergoteles, exiting entirely with an estimated $132K sold.

  • 40 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2022, down from 43 in Q4 2021.
  • Funds reported $2.25M of Nymox Pharmaceutical Corp stock for Q1 2022, up 9.8% quarter-over-quarter.
  • 8 funds opened new Nymox Pharmaceutical Corp positions in Q1 2022 and 11 closed out, a net change of -3 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q1 2022 was Citigroup, an estimated $168K added.
  • The largest Nymox Pharmaceutical Corp seller in Q1 2022 was Ergoteles, an estimated $132K sold.

Based on aggregated 13F filings for Q1 2022.